Wegovy and Contraception: What the Evidence Actually Says

What official UK guidance says about semaglutide and the pill

The starting point is the official position: NHS England's guidance on weight-management injections distinguishes clearly between tirzepatide (Mounjaro) and semaglutide (Wegovy) on this question. For tirzepatide, women using oral contraceptives are specifically advised to add a non-oral method for the first four weeks of treatment and after every dose increase, because tirzepatide's effect on gastric emptying can reduce pill absorption. The same explicit instruction does not appear for semaglutide in NHS guidance, which reflects the current evidence base rather than a general reassurance that nothing changes.

Semaglutide does slow gastric emptying, and the NHS medicines page for semaglutide notes this as a known mechanism. Slower gastric emptying can theoretically affect how quickly orally taken medicines move through the upper gut, though clinical studies with Wegovy have not shown a significant reduction in oral contraceptive hormone levels. The practical risk for most women on Wegovy comes from a different direction: if nausea or vomiting is significant during dose escalation, pill absorption can be disrupted for the same reason it is disrupted by any stomach illness. If you vomit within two hours of taking a combined pill or within three hours of a progestogen-only pill, standard missed-pill rules apply.

Worth knowing: the MHRA advises using contraception while on GLP-1 medicines as a matter of general precaution, not only because of drug interaction concerns, but because semaglutide is not recommended in pregnancy and the consequences of an unplanned pregnancy during treatment carry clinical significance. Anyone wanting to understand the wider picture of how semaglutide affects the body can read more about what Wegovy means for the heart, which is increasingly relevant context for prescribing decisions.

When vomiting makes the pill less reliable, and what to do

Early weeks on Wegovy, and the period following each dose increase, tend to bring the most pronounced gastrointestinal symptoms. For some women that includes vomiting, which is worth thinking about practically. Many women find it useful to take the oral contraceptive at a time of day when nausea is at its lowest, often later in the evening rather than first thing in the morning. If you do vomit within the absorption window after taking a pill, follow the patient information leaflet for that specific contraceptive and consider using condoms as additional cover until your next pack is safely underway.

Non-oral contraceptive methods (the coil (IUS or copper), implant, injectable, patch or vaginal ring) are unaffected by GI side effects and gastric emptying because they do not rely on gut absorption at all. If GI symptoms are a concern for you, or if you simply prefer not to think about this during the dose-escalation phase, discussing a switch with your GP or sexual health clinic before starting Wegovy is entirely sensible. If any medicines you already take might interact with a new hormonal method, that is another reason the conversation with a clinician matters.

For context on how Wegovy's GI profile compares across patients, the STEP 1 trial, published in the New England Journal of Medicine, reported nausea in around 44% of participants on semaglutide 2.4mg versus 16% on placebo, predominantly mild to moderate and most noticeable in the early months. Vomiting occurred in around 24% versus 6%. These figures give a useful sense of likelihood without predicting individual experience.

Pregnancy, conception and when to stop Wegovy

Wegovy is not licensed for use in pregnancy and is not recommended during breastfeeding. The MHRA advises women to stop semaglutide before trying to conceive, and the guidance on the specific considerations around Wegovy and pregnancy covers the timing question in more detail. In practical terms, if you are planning a pregnancy, your prescriber should be involved in deciding when to stop treatment, this is not a decision to make without clinical input, because the timing of stopping, the washout period, and any monitoring needed depends on your individual circumstances.

If pregnancy happens unexpectedly during treatment, contact your prescriber or GP the same day. Treatment will need to be stopped, and the healthcare team will want to know so appropriate monitoring can be arranged. It is also worth being aware of how Wegovy affects the liver, since this is one of the areas clinicians may want to monitor depending on your health history. Wegovy remains unsuitable for women under 18, and anyone who is pregnant, breastfeeding, or actively trying to conceive should not start treatment.

The broader pattern of what is known, what is uncertain, and where to get personalised advice mirrors the approach we take to potential interactions with other medicines taken alongside semaglutide, individual clinical review is always the right answer when the picture is complex. Our clinical team at nume takes interactions and contraindications into account during every consultation.

Practical steps before you start Wegovy

Before starting Wegovy, it is worth taking ten minutes to review your current contraceptive method with the prescriber or your GP. This is especially relevant if you rely on the oral contraceptive pill and expect significant GI side effects, or if you are in a phase of life where pregnancy is possible but not planned. A contraceptive method that does not depend on gut absorption removes one variable entirely. If you have an existing liver condition, it is also sensible to read about how Wegovy can affect liver function before your consultation, so you can raise any relevant history with your prescriber.

At nume, every prescription for Wegovy is reviewed by a GPhC-registered Independent Prescriber, a real clinician who reads your consultation answers the same day, not software processing a form. If your responses indicate you are pregnant, trying to conceive, or breastfeeding, treatment will not be prescribed. If your current contraceptive method raises a clinical question, the prescriber will raise it with you. Treatment is dispatched the same day if approved, with free next-working-day delivery, so there is no pressure to rush decisions, get the clinical picture right first. You can review all available Wegovy treatment information before starting your consultation, and see an overview of all weight-loss treatment options at nume if you are still deciding which medicine suits your situation.